Forest Laboratories To Acquire Aptalis For $2.9 Billion In Cash | Latest News RSS feed

Forest Laboratories To Acquire Aptalis For $2.9 Billion In Cash - Latest News


Aptalis to be Acquired by Forest Laboratories for $2.9 Billion

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Aptalis, a privately-held leading specialty pharmaceutical company, today announced that it has signed a definitive agreement to be acquired by Forest Laboratories ... read more

Forest Laboratories - Aptalis Deal Sparks More Enthusiasm

Acquisition Of Aptalis Forest Laboratories announced that it will acquire Aptalis for $2.9 billion in cash. Forest will acquire the privately held company from private investment firm TPG, among other... read more

Forest Labs buying Aptalis for $2.9 billion

NEW YORK (AP) — Forest Laboratories is buying Aptalis, which specializes in treatments for gastrointestinal problems and cystic fibrosis, for $2.9 billion in cash. Shares of Forest Labs surged in prem... read more

Looking for another news?


Forest Laboratories acquires Bridgewater pharma company Aptalis for $2.9B

Aptalis, a privately held specialty pharmaceutical company based in Bridgewater, said Wednesday it has agreed to be acquired by Forest Laboratories for $2.9 billion in cash. Forest Laboratories will a... read more


Forest Labs To Acquire Furiex Pharma A Deal Potentially Worth $1.46 Billion

This afternoon, Forest ... 2.9 billion acquisition of Aptalis earlier this year,” said Brent Saunders, Chief Executive Officer and President of Forest Laboratories, Inc. Furiex is a drug development c... read more

Actavis Buys Forest Labs

January 2014 Aptalis ... is acquired for $2.9 billion. February 2014 Actavis proposes $25 billion acquisition. SOURCE: Forest Labs The generic drug maker Actavis will shell out $25 billion in cash and ... read more

Actavis to buy Forest Labs in $25 billion deal (Update 3)

The Commack, N.Y., branch of Forest Laboratories, a Manhattan-based pharmaceutical company, is seen in this Aug. 4, 2004, file photo. Actavis PLC plans to buy Forest Laboratories Inc. in an approximat... read more

Deals of the Day: Candy Crush maker files for IPO

www.varonis.com OTHER M&A Actavis PLC (NYSE: ACT) has agreed to acquire Forest Laboratories Inc. (NYSE: FRX) for approximately $25 billion. The $89.48 per share deal includes $26.04 in cash ... to buy ... read more

Forest Labs buying Aptalis for $2.9 billion

Forest Laboratories is buying Aptalis, which specializes in treatments for gastrointestinal problems and cystic fibrosis, for $2.9 billion in cash. Forest Labs President and CEO Brent Saunders said in ... read more

Forest To Acquire Specialty Pharma Firm

Forest Laboratories will shell out $2.9 billion in cash to acquire privately held specialty pharmaceuticals firm Aptalis. The deal for Aptalis, which had sales of $688 million in fiscal 2013, diversif... read more

Forest Laboratories, Inc. Reports Fiscal Year Third Quarter 2014

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE ... to reduce our cost base by $500 million, raising $1.2 billion through a bond offering, and announcing plans to acquire Aptalis for $2.9 b... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us